Newswise — Dr. David Nanus, Chief, Division of Hematology and Medical Oncology, NewYork-Presbyterian and Weill Cornell Medicine:

● “The National Cancer Moonshot program will bring more resources and organization to the cancer research effort, with the same goal we physician scientists embrace – making more effective therapies available to more patients. Vice President Biden, who has unfortunately suffered the toll that cancer brings to patients and their families, is the ideal individual to lead this initiative. We will work closely together with colleagues in science, medicine, industry and government to focus on developing and implementing new approaches towards the understanding and treatment of cancer.”

Dr. Gary K. Schwartz, Chief, Division of Hematology and Oncology, NewYork-Presbyterian/Columbia University Medical Center:

● “More than ever, researchers are making extraordinary progress in understanding cancer and its complexities. There is an urgent need for government, pharmaceutical companies and physicians to come together and support the most promising work in our field. The Moonshot represents our national investment in finding new therapies and cures for cancer. It is our gift to our children and our children’s children.”

Both Dr. Nanus and Dr. Schwartz are presenting at ASCO and available on site and in New York for commentary on the Vice President’s address and the efforts of the Moonshot Initiative.

To arrange an interview with Dr. Nanus or Dr. Schwartz, email or call Dominique Grignetti (email: [email protected], phone: 646-385-4195)

MEDIA CONTACT
Register for reporter access to contact details